NCT04971785
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) treatment 2 active_not_recruiting NCT05011305
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis treatment 2 active_not_recruiting NCT05012423
FTIH Study of ECC0509 in Healthy Volunteers No drug interventions treatment 1 completed NCT05809934
A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis No drug interventions treatment 2 active_not_recruiting NCT06465186
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) treatment 2 recruiting NCT06594523
A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis treatment 3 not_yet_recruiting NCT05083390
Norursodeoxycholic Acid vs. Placebo in NASH treatment 2 recruiting NCT01205087
Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome treatment 2 completed NCT02442687
JKB-121 for the Treatment of Nonalcoholic Steatohepatitis No drug interventions treatment 2 completed NCT02933554
Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis No drug interventions treatment Not Available not_yet_recruiting NCT03439254
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis treatment 3 completed NCT04828551
Noninvasive Biomarkers of Metabolic Liver Disease 1.1 No drug interventions diagnostic Not Available completed NCT05877547
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) treatment 2 active_not_recruiting NCT01002547
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment treatment 4 completed NCT04210245
Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) treatment 2 completed NCT01399645
Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes treatment 2 completed NCT03151798
The Liver Health Study for Patients With NAFLD No drug interventions other Not Available completed NCT00842205
Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection basic_science Not Available unknown_status NCT03282305
Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese No drug interventions Not Available Not Available not_yet_recruiting NCT01679197
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy treatment 2 completed NCT05733897
Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis Not Available Not Available recruiting NCT00590161
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis treatment 2 completed NCT01828528
Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease No drug interventions Not Available Not Available completed NCT05983328
Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers No drug interventions treatment 1 completed NCT00586911
Betaine in Patients With Nonalcoholic Steatohepatitis treatment 2 completed NCT00152711
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis No drug interventions treatment Not Available unknown_status NCT04216693
Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH) treatment 2 withdrawn NCT04389593
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference No drug interventions Not Available Not Available recruiting NCT02148471
Fatty Acids, Genes and Microbiota in Fatty Liver No drug interventions Not Available Not Available completed NCT05430178
Metabolic Pathology of Pediatric NAFLD No drug interventions basic_science Not Available recruiting NCT05560607
Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease No drug interventions other 1 completed NCT05824156
CM-101 in NASH Patients - The SPLASH Study treatment 2 completed NCT02633956
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) treatment 2 completed NCT02210715
Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients screening 4 completed NCT02717000
NASH: Non-invasive Diagnostic Markers and Imaging No drug interventions Not Available Not Available unknown_status NCT02217475
Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis treatment 2 completed NCT01355575
Rifaximin in Fatty Liver Disease treatment 4 terminated NCT05309642
Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study No drug interventions treatment Not Available completed NCT04012242
Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study No drug interventions Not Available Not Available unknown_status NCT02510599
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis treatment 2 completed NCT05165706
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance No drug interventions prevention Not Available recruiting NCT04501406
Low-Dose Pioglitazone in Patients With NASH (AIM 2) treatment 2 recruiting NCT04801849
Vitamin E Dosing Study treatment 2 recruiting NCT00509418
Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis No drug interventions treatment 3 completed NCT03861819
Feasibility of VIIT in Adults With NASH No drug interventions other Not Available completed NCT01237119
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis treatment 2 completed NCT02792634
Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery No drug interventions Not Available Not Available unknown_status NCT04710524
FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis No drug interventions treatment 2 unknown_status NCT05731596
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis treatment 3 not_yet_recruiting NCT03053063
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) treatment 3 terminated NCT02077374
A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases treatment 2 completed NCT03987074
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) treatment 2 completed NCT00994682
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) treatment 4 completed NCT03248882
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) treatment 2 completed NCT03970031
A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH No drug interventions treatment 3 unknown_status NCT04166773
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) treatment 2 completed NCT03674476
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function treatment 1 completed NCT02421094
Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis treatment 2 completed NCT01466894
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis treatment 2 withdrawn NCT01919294
Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) treatment 2 completed NCT06365580
Dose Escalation Study of Kylo-0603 in Healthy Subjects No drug interventions treatment 1 recruiting NCT05343780
Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH No drug interventions supportive_care 2 completed NCT05526144
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans treatment 2 recruiting NCT03656744
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) No drug interventions treatment 2 completed NCT02307344
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis No drug interventions treatment Not Available unknown_status NCT02412540
Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH No drug interventions treatment Not Available completed NCT03332940
An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH diagnostic 1 completed NCT03028740
AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) treatment 3 terminated NCT00856869
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers diagnostic 1 / 2 completed NCT03449446
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) treatment 2 completed NCT01260246
Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes treatment Not Available terminated NCT03163810
A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH) No drug interventions treatment Not Available withdrawn NCT00740610
Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH) treatment 2 completed NCT04147195
Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) treatment 2 terminated NCT05792423
Conditionally Increased Output (CIO) Enhanced Ultrasound System No drug interventions other Not Available completed NCT05330923
Effect of NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients No drug interventions Not Available Not Available recruiting NCT04887038
First-in-Human Study of SRT-015 in Healthy Subjects. No drug interventions treatment 1 completed NCT04399538
Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis basic_science 2 completed NCT01066364
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis treatment 2 completed NCT03061721
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis treatment 2 completed NCT05655221
A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects No drug interventions treatment 1 recruiting NCT05979779
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis No drug interventions treatment 2 active_not_recruiting NCT05680233
Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis No drug interventions treatment 1 recruiting NCT00820651
Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis No drug interventions treatment 3 completed NCT02654977
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy treatment 2 completed NCT06342947
ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) No drug interventions treatment 2 active_not_recruiting NCT02764047
Probiotics in the Treatment of NAFLD No drug interventions treatment Not Available unknown_status NCT00013598
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone treatment 2 completed NCT04235205
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease treatment 2 completed NCT05029583
Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D) No drug interventions diagnostic Not Available recruiting NCT04342793
A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH No drug interventions treatment 2 completed NCT03068078
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes No drug interventions treatment Not Available completed NCT03329885
A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis treatment 1 / 2 terminated NCT00586885
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis treatment Not Available completed NCT03723252
Dapagliflozin Efficacy and Action in NASH treatment 3 completed NCT04389775
To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants No drug interventions treatment 1 completed NCT00267670
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH treatment 2 / 3 completed NCT03486899
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis treatment 2 completed NCT00583999
The Role of Leptin Receptors in NASH No drug interventions Not Available Not Available completed NCT00699036
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) treatment 2 unknown_status NCT00586313
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) No drug interventions diagnostic Not Available completed NCT01016418
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease No drug interventions treatment 1 / 2 completed NCT01051219
Anti-Fibrotic Effects of Losartan In Nash Evaluation Study treatment 3 completed NCT04565717
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) No drug interventions treatment 1 terminated NCT00794716
Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) diagnostic 2 completed NCT01094158
Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis treatment 2 completed NCT05720663
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis No drug interventions Not Available Not Available recruiting NCT02574325
A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis No drug interventions treatment 2 unknown_status NCT04595474
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes No drug interventions Not Available Not Available active_not_recruiting NCT03725631
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD No drug interventions diagnostic Not Available unknown_status NCT03676231
Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH) No drug interventions treatment 2 terminated NCT04152473
Safety and Tolerability of Oral Proglumide for NASH other 1 completed NCT03602573
Liver Fibrosis in Peri-menopausal Women No drug interventions Not Available Not Available unknown_status NCT02769091
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes No drug interventions treatment 2 withdrawn NCT02815891
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) No drug interventions Not Available Not Available recruiting NCT04031729
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease treatment 1 / 2 completed NCT03683589
De Novo Lipogenesis in Severity of NAFLD No drug interventions Not Available Not Available completed NCT00878592
Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity No drug interventions treatment Not Available terminated NCT04944992
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) treatment 2 completed NCT02083367
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome No drug interventions Not Available Not Available completed NCT05084404
Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease treatment 2 unknown_status NCT03059446
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis treatment 2 terminated NCT03486912
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis treatment 2 completed NCT00227110
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) treatment 4 completed NCT04550481
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study prevention 2 recruiting NCT04462081
Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients No drug interventions Not Available Not Available completed NCT04137055
Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics No drug interventions treatment 1 completed NCT03053050
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis treatment 3 terminated NCT04583423
A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001) No drug interventions treatment 2 terminated NCT03445208
A Study of Experimental Medication BMS-986036 Given to Healthy Participants treatment 1 completed NCT03375008
Predictable MR Index for Nonalcoholic Steatohepatitis (NASH) No drug interventions prevention Not Available completed NCT03915002
Integrated Approaches for Identifying Molecular Targets in Liver Disease No drug interventions Not Available Not Available completed NCT04707651
Formula Diet Treatment for NASH Patients. No drug interventions treatment Not Available active_not_recruiting NCT04785937
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients No drug interventions diagnostic Not Available unknown_status NCT06499675
Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study No drug interventions Not Available Not Available completed NCT05946330
Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). No drug interventions treatment Not Available active_not_recruiting NCT06537466
Ketogenic Diet in MASLD-related cACLD No drug interventions treatment Not Available not_yet_recruiting NCT04080947
The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis treatment 1 / 2 completed NCT06400771
Safety of DNP007 in Healthy Subjects No drug interventions health_services_research 1 recruiting NCT04284371
The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients No drug interventions Not Available Not Available terminated NCT06302049
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis treatment 1 / 2 recruiting NCT04175392
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis treatment 1 / 2 terminated NCT04861012
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt No drug interventions screening Not Available unknown_status NCT04932512
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 No drug interventions treatment 2 completed NCT04822181
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) treatment 3 active_not_recruiting NCT05016882
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) treatment 2 active_not_recruiting NCT05254626
Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis treatment 2 completed NCT05462353
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH No drug interventions treatment 2 recruiting NCT06054815
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects with Presumed NASH treatment 2 active_not_recruiting NCT06105060
Clinical Effects of New Approach on Patients with Non-alcoholic Steatohepatitis treatment 0 completed NCT05517564
First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease No drug interventions treatment 1 unknown_status NCT02721264
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis. treatment Not Available unknown_status NCT04666402
Integrated Diagnostics for Early Diagnosis of Liver Disease No drug interventions Not Available Not Available recruiting NCT05397379
A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis No drug interventions treatment 2 completed NCT01696487
Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. No drug interventions prevention Not Available completed NCT02235233
Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin basic_science 1 completed NCT04302051
Assessment of Fatty Liver With Thermo-acoustic Device No drug interventions Not Available Not Available recruiting NCT04722653
A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men No drug interventions treatment 1 completed NCT03377153
The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease No drug interventions treatment Not Available unknown_status NCT03432377
Coffee Consumption and NASH in the French Population. No drug interventions Not Available Not Available completed NCT04872777
Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH No drug interventions treatment Not Available completed NCT04931147
A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers No drug interventions treatment 1 completed NCT05217745
MLCT Oil for Fatty Liver - PASS Trial No drug interventions treatment Not Available unknown_status NCT02541045
Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis treatment 3 withdrawn NCT04198805
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) treatment 2 completed NCT02528305
The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis No drug interventions treatment Not Available completed NCT00677183
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children No drug interventions Not Available Not Available withdrawn NCT06308861
Phase 1 Study to Investigate Safety, Tolerability, PK/PK of J2H-1702 in Healthy Males No drug interventions treatment 1 completed NCT03674528
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD No drug interventions Not Available Not Available active_not_recruiting NCT05065593
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis No drug interventions treatment Not Available active_not_recruiting NCT01384578
Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis treatment 3 withdrawn NCT03513588
2-Week Study In People With Nonalcoholic Fatty Liver Disease No drug interventions basic_science 1 completed NCT00680407
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis treatment 2 completed NCT03883607
Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH) treatment 2 terminated NCT02395900
The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease No drug interventions treatment 2 / 3 completed NCT00492700
A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis treatment 2 completed NCT01791959
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis No drug interventions treatment 2 / 3 completed NCT00668070
A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 No drug interventions treatment 2 completed NCT04501042
Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery No drug interventions Not Available Not Available unknown_status NCT04042142
Glucagon Resistance in Patients With NAFLD No drug interventions basic_science Not Available completed NCT02970942
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. treatment 2 completed NCT05668936
A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants treatment 1 terminated NCT01766713
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis treatment 2 completed NCT03969719
A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus basic_science 2 completed NCT06569524
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) No drug interventions treatment 2 recruiting NCT04142424
A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects No drug interventions treatment 1 completed NCT04783116
Plant Stanols and Liver Inflammation in Overweight and Obese Children No drug interventions treatment Not Available unknown_status NCT04422496
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects No drug interventions treatment 1 completed NCT05294458
A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects treatment 1 completed NCT06519448
Reducing Non-Alcoholic Steatohepatitis treatment Not Available enrolling_by_invitation NCT04571957
Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After Optimization No drug interventions Not Available Not Available completed NCT06052566
A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014) treatment 1 recruiting NCT05053165
A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants treatment 1 completed NCT05751720
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue No drug interventions treatment 1 / 2 recruiting NCT03839082
Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease No drug interventions treatment Not Available completed NCT05301231
Omics-based Predictors of NAFLD/Potential NASH No drug interventions Not Available Not Available unknown_status NCT03421431
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis No drug interventions treatment 2 completed NCT04800094
Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study No drug interventions diagnostic Not Available completed NCT02686762
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis treatment 2 completed NCT02571192
A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose basic_science 1 completed NCT03377140
The Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease No drug interventions treatment Not Available unknown_status NCT03142867
The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults No drug interventions Not Available Not Available terminated NCT02413372
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) treatment 2 completed NCT04690972
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". No drug interventions Not Available Not Available not_yet_recruiting NCT01617772
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis treatment 2 unknown_status NCT03198572
Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis treatment 4 recruiting NCT03743272
Repeatability and Reproducibility of Multiparametric MRI No drug interventions Not Available Not Available unknown_status NCT03656068
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis basic_science 2 completed NCT01629095
Genetic Studies of Non-Alcoholic Fatty Liver Disease No drug interventions Not Available Not Available terminated NCT04365855
The Olmsted NAFLD Epidemiology Study (TONES) No drug interventions diagnostic Not Available recruiting NCT04829123
The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects No drug interventions treatment 1 completed NCT00681408
Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) treatment 2 / 3 completed NCT02530138
The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver No drug interventions treatment 2 / 3 unknown_status NCT04573543
The Role of Immune Semaphorins in NAFLD No drug interventions Not Available Not Available completed NCT02075164
Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD No drug interventions prevention Not Available unknown_status NCT06138821
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial No drug interventions treatment Not Available not_yet_recruiting NCT06176079
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease Not Available Not Available recruiting NCT02287779
Safety and Tolerability Study of SHP626 in Overweight and Obese Adults treatment 1 completed NCT00678587
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures treatment 3 terminated NCT02231333
The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis treatment Not Available completed NCT01056133
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) No drug interventions treatment 2 completed NCT04202354
Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH No drug interventions treatment 1 completed NCT03987451
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage treatment 2 completed NCT06552377
Ultrasound and Attenuation Imaging No drug interventions Not Available Not Available completed NCT05942547
the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis. treatment 3 recruiting NCT04190498
Sleep Apnoea Syndrome and Hepatocellular Carcinoma No drug interventions Not Available Not Available withdrawn NCT03950505
To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes treatment 4 unknown_status NCT05728697
Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease No drug interventions Not Available Not Available recruiting NCT01695083
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients No drug interventions Not Available Not Available completed NCT06160271
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis No drug interventions diagnostic 2 not_yet_recruiting NCT05766709
A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations treatment 1 completed NCT01278056
The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis treatment 1 / 2 completed NCT05945537
A Study of INI-822 in Healthy Volunteers and Participants With Non-alcoholic Steatohepatitis (NASH) or Presumed NASH No drug interventions treatment 1 recruiting NCT05357352
Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis No drug interventions Not Available Not Available completed NCT03884075
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) basic_science 2 recruiting NCT01761370
Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH) No drug interventions treatment Not Available completed NCT03535142
Prognostic Significance of Fatty Liver Disease in Bariatric Patients No drug interventions diagnostic Not Available recruiting NCT04190849
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) No drug interventions Not Available Not Available recruiting NCT05574036
Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia treatment 2 recruiting NCT01279434
Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial treatment Not Available withdrawn NCT06297434
Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH No drug interventions treatment 2 recruiting NCT02279524
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH treatment 2 completed NCT05480696
Soluble Fibre Supplementation in NAFLD No drug interventions treatment 1 recruiting NCT03664596
Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis treatment Not Available completed NCT05463796
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer No drug interventions Not Available Not Available recruiting NCT05605158
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis treatment 3 not_yet_recruiting NCT04669158
Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis treatment 1 / 2 active_not_recruiting NCT03864835
NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal No drug interventions treatment Not Available withdrawn NCT03400163
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) treatment 2 completed NCT00977730
The Effect of Protandim on Non-alcoholic Steatohepatitis No drug interventions treatment Not Available completed NCT05357248
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH No drug interventions treatment Not Available completed NCT02314026
BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH No drug interventions diagnostic 2 completed NCT04171765
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis treatment 2 terminated NCT03524365
Bariatric Surgery Versus Non-alcoholic Steato-hepatitis No drug interventions treatment Not Available completed NCT04579874
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. No drug interventions diagnostic Not Available completed NCT06308874
Phase 1 Study to Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females No drug interventions treatment 1 completed NCT03863574
Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis treatment 2 completed NCT03437720
Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease No drug interventions treatment 2 withdrawn NCT02912260
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) treatment 2 unknown_status NCT05835180
A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function treatment 1 completed NCT04537780
Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH) treatment 4 completed NCT03812029
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) treatment 2 completed NCT02880189
EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity No drug interventions supportive_care Not Available completed NCT02784444
A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH No drug interventions treatment 2 completed NCT03803540
Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis No drug interventions treatment 1 unknown_status NCT05848440
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants No drug interventions treatment 1 completed NCT02787304
Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) treatment 2 terminated NCT05573204
Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients With Non-alcoholic Steatohepatitis treatment 2 active_not_recruiting NCT02960204
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension treatment 2 completed NCT03198104
Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI No drug interventions Not Available Not Available completed NCT01674972
Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls No drug interventions Not Available Not Available completed NCT04182646
Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease No drug interventions treatment Not Available unknown_status NCT03734510
The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled Study No drug interventions treatment Not Available unknown_status NCT05821010
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis treatment 2 recruiting NCT04378010
A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH No drug interventions treatment 2 terminated NCT02681055
Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects treatment 2 completed NCT05623150
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome No drug interventions Not Available Not Available not_yet_recruiting NCT04657523
Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study No drug interventions diagnostic Not Available completed NCT03962608
Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis No drug interventions treatment Not Available withdrawn NCT04806750
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension treatment 2 completed